Quoin Pharmaceuticals, Ltd.QNRXNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank23
Year-over-Year Change
Year-over-year earnings per share growth rate
Percentile
P23
Within normal range
vs 5Y Ago
-1.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -6.85% |
| Q2 2025 | 3.38% |
| Q1 2025 | 47.45% |
| Q4 2024 | 24.80% |
| Q3 2024 | -4117.95% |
| Q2 2024 | 65.18% |
| Q1 2024 | 46.67% |
| Q4 2023 | -7.69% |
| Q3 2023 | 8.45% |
| Q2 2023 | 11.98% |
| Q1 2023 | 50.51% |
| Q4 2022 | 64.15% |
| Q3 2022 | -40.33% |
| Q2 2022 | 54.32% |
| Q1 2022 | 100.00% |
| Q4 2021 | -679021.95% |
| Q3 2021 | 67.63% |
| Q2 2021 | -11.11% |
| Q1 2021 | -1433.31% |
| Q4 2020 | 22.43% |
| Q3 2020 | 6.28% |
| Q2 2020 | 48.31% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q4 2016 | 0.00% |